Impact of Revaluation 2023 on Healthcare
The recent changes to healthcare sector property assessments, effective 1 April 2023, offer a somewhat mixed picture. While the national average increase in value ranges between 10% and 20% depending on the property type, there is considerable variation within this range. Some properties may see only modest increases, but our analysis suggests that this could be due to their previous assessments being undervalued. It’s worth noting that while most commercial properties were subject to lockdown restrictions as of 1 April 2021, the effective date for the 2023 Revaluation in England and Wales, most healthcare properties were operational. Therefore, the impact of the COVID-19 pandemic on assessments is less apparent but still important to consider in reviewing them. In England and Wales, these Rateable Values can now be challenged through the Check, Challenge, Appeal process.
Transitional Relief
Positively, for the first time since 1990, there isn’t a scheme to phase in reductions, properties receiving decreased Rateable Values, and bills, immediately.
England and Wales
Previous revaluations across the UK led to initiatives that capped increases in rate liabilities. However, for the 2023 Revaluation, there is limited relief for healthcare providers where the Rateable Value above £100,000 will only see relief if the 2023/2024 liability increase exceeds 30%.
Scotland
Scotland has introduced transitional phasing for the first time, although the scheme is more adverse than England’s, with large properties having their liability increases capped at 37.5%.
Wales
The Welsh Government’s scheme is more favourable, providing relief to ratepayers who continue in occupation, facing an increase of over £300. Here, the increase is phased over two years.
Regulatory compliance
England and Wales
Non-Domestic Rating Act 2023
The Non-Domestic Rating Act 2023 will introduce potentially onerous mandatory obligations on ratepayers to regularly update the tenure and physical details of all properties within their portfolios with the Valuations Office Agency (VOA).
Increasing the administrative burden on businesses, it will require prompt updates to the VOA and annual returns even where there are no changes, with penalty risks for non-compliance. The complexity of business rates management will increase with measures anticipated to be fully in place for the 2026 Revaluation.
Material Change of Circumstance (MCC)
Legislative changes to Material Change of Circumstance provisions took immediate effect in October 2023. They tighten the scope of MCCs in England so that new legislation, licensing regimes and guidance from public bodies will not be grounds for a change in Rateable Value between revaluations.
Completion Notices
For buildings that have been temporarily removed from the rating list during redevelopment, billing authorities will be able to issue Completion Notices in the same way as for a new building. The regulatory changes should be in effect from January 2024.
Scotland
Since January 2023, Scotland’s new legislation has transferred Valuation Appeals to the Scottish Courts Tribunal service. This entails strict deadlines and rigorous requirements for ratepayers and advisors. All appeals against valuations from April 2023 should have been submitted as a comprehensive case with supporting data by 31 August 2023. Learn more about how to appeal business rates in Scotland >
How we can help
Bringing vast experience and industry-specific knowledge, our specialists offer expert insights on how to minimise business rate liabilities. We understand the complexity of the healthcare sector (whether NHS, private or not-for-profit), ranging from the latest acute hospitals through to specialist rehabilitation centres and emerging care plus formats. Our approach is as far removed from a one-off ‘in-and-out’ rating appeal service as it is possible to imagine. We stay close to clients throughout the revaluation period, tracking changes to estates, spotting opportunities for mitigation and providing regular liability forecasting and strategic advice.